Dan H. Moore

Belfast Health and Social Care Trust — United Kingdom

Biochemistry, Genetics and Molecular Biology · Life Sciences

100h-index34.0kcitations660works2.32yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Virus-based gene therapy research(65), Amyotrophic Lateral Sclerosis Research(57), Breast Cancer Treatment Studies(37), Animal Virus Infections Studies(33), Carcinogens and Genotoxicity Assessment(30)

Publications659 total

Engagement and retention in HIV care in rural Southern U.S. using an All-Payer Claims Database
PLoS ONE·2025Open Access
S4 Effects of hyperoxia on pulmonary inflammation and organ injury in a human <i>in vivo</i> model (HIPI): a randomised, double-blind, placebo-controlled trial
2025· 1 cited
Affordability matters: A cross-sectional study on sunscreen cost and application amount
Journal of the American Academy of Dermatology·2025· 3 citedOpen Access
A 40‐week phase <scp>2B</scp> randomized, multicenter, double‐blind, placebo‐controlled study evaluating the safety and efficacy of memantine in amyotrophic lateral sclerosis
Muscle & Nerve·2024· 4 citedOpen Access
Training volume, intensity, and performance of world-class Chinese rowers prior to the 2019 world championships: A case study
International Journal of Sports Science & Coaching·2024· 5 cited
50709 Sun protective behaviors among patients at higher risk for melanoma
Journal of the American Academy of Dermatology·2024
Validation of a Community-Based Approach Toward Personalized Dementia Risk Reduction: The Kimel Family Centre for Brain Health and Wellness
The Journal of Prevention of Alzheimer s Disease·2024· 3 citedOpen Access
A 40-week Phase 2B Randomized, Multicenter, Double-blind, Placebo-controlled Study Evaluating the Safety and Efficacy of Memantine in Amyotrophic Lateral Sclerosis (P8-8.011)
Neurology·2023· 2 cited
Supplementary Figure 2 from Cannabidiol Enhances the Inhibitory Effects of Δ&lt;sup&gt;9&lt;/sup&gt;-Tetrahydrocannabinol on Human Glioblastoma Cell Proliferation and Survival
2023Open Access
Data from Elevated Cutaneous Smad Activation Associates with Enhanced Skin Tumor Susceptibility in Organ Transplant Recipients
2023Open Access
Supplementary Table 1, Figure Legends 1-2 from Cannabidiol Enhances the Inhibitory Effects of Δ&lt;sup&gt;9&lt;/sup&gt;-Tetrahydrocannabinol on Human Glioblastoma Cell Proliferation and Survival
2023Open Access
Data from Cannabidiol Enhances the Inhibitory Effects of Δ&lt;sup&gt;9&lt;/sup&gt;-Tetrahydrocannabinol on Human Glioblastoma Cell Proliferation and Survival
2023Open Access
Supplementary Figure 1 from Cannabidiol Enhances the Inhibitory Effects of Δ&lt;sup&gt;9&lt;/sup&gt;-Tetrahydrocannabinol on Human Glioblastoma Cell Proliferation and Survival
2023Open Access
Data from Cannabidiol Enhances the Inhibitory Effects of Δ&lt;sup&gt;9&lt;/sup&gt;-Tetrahydrocannabinol on Human Glioblastoma Cell Proliferation and Survival
2023Open Access
Supplementary Data from Elevated Cutaneous Smad Activation Associates with Enhanced Skin Tumor Susceptibility in Organ Transplant Recipients
2023Open Access
Supplementary Table 1, Figure Legends 1-2 from Cannabidiol Enhances the Inhibitory Effects of Δ&lt;sup&gt;9&lt;/sup&gt;-Tetrahydrocannabinol on Human Glioblastoma Cell Proliferation and Survival
2023Open Access
Data from Elevated Cutaneous Smad Activation Associates with Enhanced Skin Tumor Susceptibility in Organ Transplant Recipients
2023Open Access
Supplementary Data from Elevated Cutaneous Smad Activation Associates with Enhanced Skin Tumor Susceptibility in Organ Transplant Recipients
2023Open Access
Supplementary Figure 1 from Cannabidiol Enhances the Inhibitory Effects of Δ&lt;sup&gt;9&lt;/sup&gt;-Tetrahydrocannabinol on Human Glioblastoma Cell Proliferation and Survival
2023Open Access
Supplementary Figure 2 from Cannabidiol Enhances the Inhibitory Effects of Δ&lt;sup&gt;9&lt;/sup&gt;-Tetrahydrocannabinol on Human Glioblastoma Cell Proliferation and Survival
2023Open Access
page 1 of 33Next →

Frequent Co-authors

Ann D. Thor(5), Laura J. Esserman(5), Karen Chew(5), Brian H. Mayall(4), Christopher C. Benz(4), Robert G. Miller(4), Frederic M. Waldman(4), Noel Weidner(3), Helene S. Smith(3), John Ravits(3), Richard J. Barohn(3), Elisabeth R. Garwood(3), Joe W. Gray(3), Robert G. Miller(2), S M Edgerton(2), Hiroshi Mitsumoto(2), Hans E. Neville(2), H. Ruska(2), Stephen Bent(2), Michael J. Campbell(2)